The transition of acute to chronic bowel inflammation in spondyloarthritis (Q38003085)

26 August 2017

title

The transition of acute to chronic bowel inflammation in spondyloarthritis (English)

1 reference

26 August 2017

2

Peggy Jacques

1 reference

26 August 2017

Liesbet Van Praet

1

1 reference

26 August 2017

Filip Van den Bosch

series ordinal

3

1 reference

26 August 2017

Dirk Elewaut

series ordinal

4

1 reference

26 August 2017

language of work or name

English

0 references

publication date

17 April 2012

1 reference

Nature Reviews Rheumatology

26 August 2017

published in

1 reference

26 August 2017

volume

8

1 reference

26 August 2017

issue

5

1 reference

26 August 2017

page(s)

288-295

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

26 August 2017

1 reference

Concepts and epidemiology of spondyloarthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Diagnosis and classification in spondyloarthritis: identifying a chameleon

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Treatment of ankylosing spondylitis and extra-articular manifestations in everyday rheumatology practice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Clinically silent inflammatory gut lesions in undifferentiated spondyloarthropathies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

High frequency of silent inflammatory bowel disease in spondylarthropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Course of gut inflammation in spondylarthropathies and therapeutic consequences

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Joint expedition: linking gut inflammation to arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Histopathology of intestinal inflammation related to reactive arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Genetics of spondyloarthritis--beyond the MHC.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

A common genetic background for inflammatory bowel disease and ankylosing spondylitis: a genealogic study in Iceland

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Inflammatory bowel disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Recent Insights Into the Genetics of Inflammatory Bowel Disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

A genome-wide association study identifies IL23R as an inflammatory bowel disease gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

In vivo role of ER-associated peptidase activity in tailoring peptides for presentation by MHC class Ia and class Ib molecules

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Identification of ARTS-1 as a novel TNFR1-binding protein that promotes TNFR1 ectodomain shedding

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

The genetic basis of spondyloarthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Association of variants at 1q32 and STAT3 with ankylosing spondylitis suggests genetic overlap with Crohn's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Developments in therapies for spondyloarthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Analysis of JAK2 and STAT3 polymorphisms in patients with ankylosing spondylitis in Chinese Han population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Genetic analysis of innate immunity in Crohn's disease and ulcerative colitis identifies two susceptibility loci harboring CARD9 and IL18RAP.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Elucidating the chromosome 9 association with AS; CARD9 is a candidate gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

CARD15 gene polymorphisms in patients with spondyloarthropathies identify a specific phenotype previously related to Crohn's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Serological markers in inflammatory bowel disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Anti-saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

pANCA, ASCA, and OmpC Antibodies in Patients with Ankylosing Spondylitis without Inflammatory Bowel Disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Monitoring disease activity by stool analyses: from occult blood to molecular markers of intestinal inflammation and damage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Inflammatory bowel disease serologies in ankylosing spondylitis patients: a pilot study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Calprotectin in ankylosing spondylitis – frequently elevated in feces, but normal in serum

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Subclinical intestinal inflammation and sacroiliac changes in relatives of patients with ankylosing spondylitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

The role of bacteria in the pathogenesis of inflammatory bowel disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Dysbiosis of fecal microbiota in Crohn's disease patients as revealed by a custom phylogenetic microarray

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

The Bowel Microbiota and Inflammatory Bowel Diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Development and maintenance of the gut-associated lymphoid tissue (GALT): the roles of enteric bacteria and viruses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Factors affecting the lymphoid cells in the small intestinal epithelium of the mouse

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Time for a gut check: evidence for the hypothesis that HLA-B27 predisposes to ankylosing spondylitis by altering the microbiome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Guilt by association: HLA-B27 and ankylosing spondylitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Cell-surface expression and immune receptor recognition of HLA-B27 homodimers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Paneth cell antimicrobial peptides: topographical distribution and quantification in human gastrointestinal tissues.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Reduced Paneth cell alpha-defensins in ileal Crohn's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Over-expression of paneth cell-derived anti-microbial peptides in the gut of patients with ankylosing spondylitis and subclinical intestinal inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Natural killer T cells and autoimmune disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Regulatory T cells exert checks and balances on self tolerance and autoimmunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Mechanisms of suppression by suppressor T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

The unique role of natural killer T cells in the response to microorganisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Characterization of FOXP3+CD4+ regulatory T cells in Crohn's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Expansion of intestinal CD4+CD25(high) Treg cells in patients with ankylosing spondylitis: a putative role for interleukin-10 in preventing intestinal Th17 response.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Therapy with anti-TNFα antibody enhances number and function of Foxp3+ regulatory T cells in inflammatory bowel diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Peripheral regulatory T cells and serum transforming growth factor-β: relationship with clinical response to infliximab in Crohn's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Synovial and peripheral blood CD4+FoxP3+ T cells in spondyloarthritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Invariant natural killer T cells are natural regulators of murine spondylarthritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis: influence of disease duration and activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFalpha

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Differential Th1/Th2 cytokine patterns in chronic arthritis: interferon gamma is highly expressed in synovium of rheumatoid arthritis compared with seronegative spondyloarthropathies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Macrophages expressing the scavenger receptor CD163: a link between immune alterations of the gut and synovial inflammation in spondyloarthropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Systemic levels of IL-23 are strongly associated with disease activity in rheumatoid arthritis but not spondyloarthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Progress in spondylarthritis. Immunopathogenesis of spondyloarthritis: which cells drive disease?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Association of interleukin-23 receptor variants with ankylosing spondylitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Analysis of IL-17(+) cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Intestinal epithelial cells as producers but not targets of chronic TNF suffice to cause murine Crohn-like pathology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

IL-22 induces lipopolysaccharide-binding protein in hepatocytes: a potential systemic role of IL-22 in Crohn's disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Enterotypes of the human gut microbiome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Subclinical gut inflammation in spondyloarthritis is associated with a pro-angiogenic intestinal mucosal phenotype

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.42

Gut inflammation in the spondyloarthropathies: clinical, radiologic, biologic and genetic features in relation to the type of histology. A prospective study

31 March 2020

1 reference

12 December 2020

Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association

1 reference

12 December 2020

Gut inflammation in psoriatic arthritis: a prospective ileocolonoscopic study

1 reference

12 December 2020

Gut inflammation in children with late onset pauciarticular juvenile chronic arthritis and evolution to adult spondyloarthropathy--a prospective study

1 reference

12 December 2020

Macroscopic and microscopic gut lesions in seronegative spondyloarthropathies

1 reference

12 December 2020

IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis

1 reference

12 December 2020

The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects.

1 reference

12 December 2020

The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRRHEUM.2012.42

1 reference

Dimensions Publication ID

26 August 2017

1044633415

0 references

1 reference